Medifast's (NYSE:MED) Q1 Earnings Results: Revenue In Line With Expectations But Stock Drops 14.3% [Yahoo! Finance]
MEDIFAST INC (MED)
Last medifast inc earnings: 2/26 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.medifastnow.com
Company Research
Source: Yahoo! Finance
On the other hand, next quarter's revenue guidance of $160 million was less impressive, coming in 10.4% below analysts' estimates. It made a GAAP profit of $0.76 per share, down from its profit of $3.67 per share in the same quarter last year. Is now the time to buy Medifast? Find out in our full research report Medifast (MED) Q1 CY2024 Highlights: Revenue: $174.7 million vs analyst estimates of $173.5 million (small beat) EPS: $0.76 vs analyst expectations of $0.80 (5% miss) Revenue Guidance for Q2 CY2024 is $160 million at the midpoint, below analyst estimates of $178.5 million (EPS guidance for the same period was well below expectations) Gross Margin (GAAP): 72.8%, up from 70.6% in the same quarter last year Market Capitalization: $364.9 million “Fast paced medical innovation is providing greater access to medical weight loss solutions than ever before. We are transforming our OPTAVIA offer to include comprehensive support for consumers who wish to use GLP-1 medica
Show less
Read more
Impact Snapshot
Event Time:
MED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MED alerts
High impacting MEDIFAST INC news events
Weekly update
A roundup of the hottest topics
MED
News
- INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the FirmAccesswire
- Medifast, Inc. (MED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsAccesswire
- Medifast, Inc. (MED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsAccesswire
- Medifast, Inc. (MED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsAccesswire
- Medifast, Inc. (MED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsAccesswire
MED
Earnings
- 4/29/24 - Beat
MED
Sec Filings
- 5/8/24 - Form ARS
- 4/29/24 - Form 10-Q
- 4/29/24 - Form 8-K
- MED's page on the SEC website